Bromoenol lactone, an inhibitor of Group V1A calcium-independent phospholipase A 2 inhibits antigen-stimulated mast cell exocytosis without blocking Ca 2+ influx
Cell Calcium, ISSN: 0143-4160, Vol: 41, Issue: 2, Page: 145-153
2007
- 17Citations
- 14Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations17
- Citation Indexes17
- CrossRef17
- 15
- Captures14
- Readers14
- 14
Article Description
Calcium-independent phospholipase A 2 (iPLA 2 β) has recently been suggested to regulate Ca 2+ entry by activating store-operated Ca 2+ channels. These studies have been conducted in mast cells using thapsigargin to deplete intracellular stores. In RBL 2H3 and bone marrow-derived mast cells (BMMCs), Ca 2+ entry is critical for exocytosis and therefore we have examined whether the proposed mechanism would be relevant when a physiological stimulus is applied to these cells. Using an iPLA 2 β antibody, we demonstrate that the 84 kDa iPLA 2 β is expressed in these mast cells. As bromoenol lactone (BEL) is a suicide-based irreversible inhibitor of iPLA 2 β it was used to probe this potential mechanism. We observe inhibition of exocytosis stimulated either with antigen or with thapsigargin. However, BEL also inhibits exocytosis when stimulated using a Ca 2+ ionophore A23187, which passively transports Ca 2+ down a concentration gradient and also in permeabilised mast cells where Ca 2+ entry is no longer relevant. Moreover, BEL has only a minor effect on antigen- or thapsigargin-stimulated Ca 2+ signalling, both the release from internal stores and sustained elevation due to Ca 2+ influx. These results cast doubt on the proposed mechanism involving iPLA 2 β required for Ca 2+ entry. Although inhibition of exocytosis by BEL could imply a requirement for iPLA 2 β activation for exocytosis, an alternative explanation is that BEL inactivates other target proteins required for exocytosis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S014341600600114X; http://dx.doi.org/10.1016/j.ceca.2006.06.002; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33845742173&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/16854462; https://linkinghub.elsevier.com/retrieve/pii/S014341600600114X; https://dx.doi.org/10.1016/j.ceca.2006.06.002
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know